Zobrazeno 1 - 10
of 343
pro vyhledávání: '"Jeffrey J, Tosoian"'
Autor:
Orczyk C; Division of Surgery and Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals, London, UK. Electronic address: c.orczyk@ucl.ac.uk., Marsden T; Division of Surgery and Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals, London, UK., Emberton M; Division of Surgery and Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals, London, UK.
Publikováno v:
European urology [Eur Urol] 2021 Mar; Vol. 79 (3), pp. e98-e99. Date of Electronic Publication: 2020 Dec 16.
Autor:
Udit Singhal, Srinivas Nallandhighal, Jeffrey J. Tosoian, Kevin Hu, Trinh M. Pham, Judith Stangl-Kremser, Chia-Jen Liu, Razeen Karim, Komal R. Plouffe, Todd M. Morgan, Marcin Cieslik, Roberta Lucianò, Shahrokh F. Shariat, Nadia Finocchio, Lucia Dambrosio, Claudio Doglioni, Arul M. Chinnaiyan, Scott A. Tomlins, Alberto Briganti, Ganesh S. Palapattu, Aaron M. Udager, Simpa S. Salami
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-9 (2024)
Abstract Localized prostate cancer is frequently composed of multiple spatially distinct tumors with significant inter- and intra-tumoral molecular heterogeneity. This genomic diversity gives rise to many competing clones that may drive the biologica
Externí odkaz:
https://doaj.org/article/62b4741b814f4ceeb89934d4333d96c5
Autor:
Mai Z; Department of Urology, Zhongshan City People's Hospital, Zhongshan, Guangdong, China., Yuan R; Department of Urology, Zhongshan City People's Hospital, Zhongshan, Guangdong, China. Electronic address: huk5588@163.com.
Publikováno v:
European urology [Eur Urol] 2020 Sep; Vol. 78 (3), pp. e133-e134. Date of Electronic Publication: 2020 May 20.
Autor:
Froehner M; Department of Urology, Zeisigwaldkliniken Bethanien Chemnitz, Chemnitz, Germany. Electronic address: Michael.Froehner@ediacon.de., Koch R; Department of Urology, University Hospital 'Carl Gustav Carus', Technische Universität Dresden, Dresden, Germany., Thomas C; Department of Urology, University Hospital 'Carl Gustav Carus', Technische Universität Dresden, Dresden, Germany.
Publikováno v:
European urology [Eur Urol] 2020 Aug; Vol. 78 (2), pp. e91. Date of Electronic Publication: 2020 May 04.
Publikováno v:
European urology. 78(2)
Publikováno v:
Eur Urol
BACKGROUND: The potential for low-grade (grade group 1 [GG1]) prostate cancer (PCa) to progress to high-grade disease remains unclear. OBJECTIVE: To interrogate the molecular and biological features of low-grade PCa serially over time. DESIGN, SETTIN
Autor:
Runqiang Yuan, Zhipeng Mai
Publikováno v:
European Urology. 78:e133-e134
Autor:
Tosoian JJ; The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA., Trock BJ; The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA., Ballentine Carter H; The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA., Mamawala M; The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA. Electronic address: mmamawa1@jhmi.edu.
Publikováno v:
European urology [Eur Urol] 2017 Jan; Vol. 71 (1), pp. e13. Date of Electronic Publication: 2016 Jun 13.
Autor:
Yan W; Urology Department, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China. Electronic address: ywgpumch@sina.com., Zhou Z; Urology Department, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China., Li H; Urology Department, Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China.
Publikováno v:
European urology [Eur Urol] 2017 Jan; Vol. 71 (1), pp. e12. Date of Electronic Publication: 2016 Jun 01.
Autor:
Mingjian Shi, John P. Shelley, Kerry R. Schaffer, Jeffrey J. Tosoian, Minoo Bagheri, John S. Witte, Linda Kachuri, Jonathan D. Mosley
Publikováno v:
EBioMedicine, Vol 97, Iss , Pp 104838- (2023)
Summary: Background: Prostate-specific antigen (PSA) levels are influenced by genetic variation unrelated to prostate cancer risk. Whether a genetic predisposition to a higher PSA level predisposes to a diagnostic work-up for prostate cancer is not k
Externí odkaz:
https://doaj.org/article/569bdb9e3add45e7bb33a4cdf5d17c2b